983 related articles for article (PubMed ID: 12754525)
1. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
Puigserver P; Rhee J; Donovan J; Walkey CJ; Yoon JC; Oriente F; Kitamura Y; Altomonte J; Dong H; Accili D; Spiegelman BM
Nature; 2003 May; 423(6939):550-5. PubMed ID: 12754525
[TBL] [Abstract][Full Text] [Related]
2. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
3. PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism.
Lee J; Salazar Hernández MA; Auen T; Mucka P; Lee J; Ozcan U
Mol Metab; 2018 Jan; 7():119-131. PubMed ID: 29129613
[TBL] [Abstract][Full Text] [Related]
4. Role of HDAC9-FoxO1 Axis in the Transcriptional Program Associated with Hepatic Gluconeogenesis.
Chen J; Zhang Z; Wang N; Guo M; Chi X; Pan Y; Jiang J; Niu J; Ksimu S; Li JZ; Chen X; Wang Q
Sci Rep; 2017 Jul; 7(1):6102. PubMed ID: 28733598
[TBL] [Abstract][Full Text] [Related]
5. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, Akt, FoxO1 and PGC-1α in livers of obese and type 2 diabetic humans.
Sajan MP; Ivey RA; Farese RV
Metabolism; 2015 Nov; 64(11):1454-65. PubMed ID: 26386696
[TBL] [Abstract][Full Text] [Related]
6. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
[TBL] [Abstract][Full Text] [Related]
7. Baicalin ameliorates hepatic insulin resistance and gluconeogenic activity through inhibition of p38 MAPK/PGC-1α pathway.
Fang P; Sun Y; Gu X; Shi M; Bo P; Zhang Z; Bu L
Phytomedicine; 2019 Nov; 64():153074. PubMed ID: 31473580
[TBL] [Abstract][Full Text] [Related]
8. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
9. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis attenuates the insulin-induced phosphorylation and translocation of forkhead box protein O1 in human hepatocytes.
Takamura H; Yoshida K; Okamura H; Fujiwara N; Ozaki K
Arch Oral Biol; 2016 Sep; 69():19-24. PubMed ID: 27214121
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional coactivator NT-PGC-1α promotes gluconeogenic gene expression and enhances hepatic gluconeogenesis.
Chang JS; Jun HJ; Park M
Physiol Rep; 2016 Oct; 4(20):. PubMed ID: 27798359
[TBL] [Abstract][Full Text] [Related]
12. miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α.
Fang Z; Li P; Jia W; Jiang T; Wang Z; Xiang Y
Int J Mol Med; 2016 Sep; 38(3):845-52. PubMed ID: 27432632
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
15. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice.
Ji LN; Wu S; Fu DQ; Fang SJ; Xie GQ; Fan YS; Bao J
J Ethnopharmacol; 2022 Feb; 284():114815. PubMed ID: 34763039
[TBL] [Abstract][Full Text] [Related]
16. Garcinol promotes hepatic gluconeogenesis by inhibiting P300/CBP-associated factor in late-pregnant sows.
Yao W; Xia J; Wang T; Li J; Huang L; Huang F
Br J Nutr; 2021 Jul; 126(1):1-8. PubMed ID: 32967737
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
[TBL] [Abstract][Full Text] [Related]
18. The Methionine Transamination Pathway Controls Hepatic Glucose Metabolism through Regulation of the GCN5 Acetyltransferase and the PGC-1α Transcriptional Coactivator.
Tavares CD; Sharabi K; Dominy JE; Lee Y; Isasa M; Orozco JM; Jedrychowski MP; Kamenecka TM; Griffin PR; Gygi SP; Puigserver P
J Biol Chem; 2016 May; 291(20):10635-45. PubMed ID: 27022023
[TBL] [Abstract][Full Text] [Related]
19. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
[TBL] [Abstract][Full Text] [Related]
20. FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes.
Chi Y; Meng Y; Wang J; Yang W; Wu Z; Li M; Wang D; Gao F; Geng B; Tie L; Zhang W; Yang J
J Cell Mol Med; 2019 Mar; 23(3):1746-1758. PubMed ID: 30488666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]